1. Introduction {#sec0005}
===============

Natural products have been known as unique source for delivering many bioactive lead compounds for drug discovery. Plants, animals and microorganisms represent unlimited reservoirs for these natural products. In Particular, plants produce various metabolites that play a major role in their adaptation to certain environment. Several thousands of these compounds have been claimed to possess medicinal properties which can be used directly or as pharmaceutical agents [@bib0005]. Therefore, the plants possess specific activity; named as "herbal plants"; have been used by folk traditions for treating several diseases a century ago and represent a renewable source of natural products and chemical entities [@bib0010].

These natural products, nowadays, continue to provide a diverse and unique source of bioactive lead compounds for drug novelty especially with renewed interest for this source which considered as promising alternative medicines [@bib0015]. Additionally, there is an emerging increase in the intake of plant formulation as alternative drugs for the strong belief that these products are safe and devoid of toxic side effects [@bib0020]. Meanwhile, their acceptability, effectiveness, affordability, safety and low cost give more attention to use them as alternative medicine [@bib0025], [@bib0030]. *Moringa* tree, a member of family Moringaceae, is considered among these medicinal plants which have multiuse as folk and nutritive medicine [@bib0035]. It occurs in arid desert mountains. It is currently threatened in large part of its distribution range in the Middle East and the Arabian Peninsula due to the high rate of its consumption. It is native to the southern foothills of the Himalayas in northwestern India. Today, *Moringa* tree is widely cultivated in tropical and subtropical areas where its young seed pods and leaves are used as vegetables. There are thirteen species of *Moringa* are known worldwide, *M.oleifera* is the most distributed species beyond its origin [@bib0040]. It has already in use for several medical purposes and the evidence for its therapeutic practices have been reported by many studies [@bib0045]. The second popular *M* species is *M. peregrina* (Forssk.) Fiori., a small tree widely adapted to different harsh ecological conditions [@bib0050], [@bib0055], [@bib0060]. It geographically distributed from tropical Africa to east India. Nearly all parts of this plant species are culturally consumed by human, in its habitats, for its nutritional value and for its taste and flavor as a vegetable.

*Moringa peregrina* can also be used in herbal medicine for treatment of fever, headache, malaria, constipation, abdominal pains, muscle pains, hypertension, vasodilator activity, asthma, diabetes and burns in folk medicine [@bib0050]. Further pharmacological studies have shown the ability of this *M*. species to be used as antioxidant [@bib0065], analgesic, anti-inflammatory [@bib0070], antiulcer, anti-hyperglycemic [@bib0075], anti-hyperlipidemic, antimicrobial activities [@bib0070], [@bib0080].

In Egypt, *Moringa peregrina* (Forssk.) Fiori. is the only native species occurs in Egyptian habitat among the thirteen species distributed all over the world. It is characterized by a very fast growth that can reach 3--5 m in height after 10 months of plantation time [@bib0060]. *M. peregrina* seeds have diminutive germination time and high seedling growth rate. Trees of *M. peregrina* bear 20--40 cm-long seed pods, each were containing 5--15 unwinged seeds. The seed kernel has high oil content in the range of 42--54% of its weight [@bib0085]. The Egyptian Bedouin used the seeds as a medicinal plant due to its composition of oil. It also used by pregnant woman for strengthen the muscles, health condition and facilitate the fetus delivery.

Many studies have been carried out to explore the medicinal properties of *Moringa* species; however, the most of the studies done were on *M. oleifera* and no studies were carried out for testing the toxicity and medical activates of naturally occurred *M. peregerina* in Saint Katherine area, South Sinai, Egypt. In the meantime, using this plant by local Bedouin often look at the medicinal benefits and neglect their toxic effects which may affect various human organs. For such purpose we collected *Moringa* seeds from its unique habitats in Saint Katherine area and used them to evaluate their toxicity for human uses.

2. Material and methods {#sec0010}
=======================

2.1. Collection and identification of plant material {#sec0015}
----------------------------------------------------

Fresh mature seed pots of *M. peregrina* trees, grown on the foot-hills and draining slopes of the higher mountains in South Sinai were collected. The plant was identified and authenticated taxonomically in Botany department, Faculty of Science, Suez Canal University. The seed pods were left to dry after then the seeds were collected from opened-dry pods. The seeds were peeled off and coat peeled-seeds were used.

2.2. Experimental animals {#sec0020}
-------------------------

Twenty four young adult male albino rats, weighed between 120 and 150 g, were used in this study. They were fed with regular diet and tap water *ad libitum*. The rodents were housed under standard laboratory environment, and allowed to acclimatize to the laboratory environment (temperature of 28 ± 2 °C with relative humidity and naturally illuminated environment of 12/12 h day light/dark cycles) for two weeks before being used in the experiment. The experiment was performed in accordance with the internationally accepted standard ethical guidelines for laboratory animal use and care as described in the European Community guidelines [@bib0090].

2.3. Animal treatments and experimental protocol {#sec0025}
------------------------------------------------

The experimental protocol, designed to evaluate toxicity of *Moringa* seeds, was in accordance to the guideline of Diderich [@bib0095], [@bib0100], [@bib0105]. Twenty four rats were randomly divided into four groups with six rats each. Following an overnight fasting, the rats were weighted and the doses of *M. peregerina* seeds were calculated in reference to their body weight (BW). The groups were as follow: the control group, which received no treatment and feed normal diet; group one (G1), group 2 (G2) and group 3 (G3) were treated with *Moringa* seeds at doses 500, 1000 and 2000 mg/Kg BW, respectively. The seeds were crushed, after removing the outer fibrous covers, and daily administrated orally for 14 days in their diet. The rat\'s observation and monitoring was made for a period of 14 days for any signs of toxicity, mortality, behavior and clinical symptoms [@bib0100], [@bib0105]. On the day14th of the running experiment, following an overnight fasting, all animals in designed groups were anesthetized under chloroform vapor and blood samples were collected by cardiac puncture [@bib0110] and injected into non-heparin\'s bottles for biochemical investigations. Collected blood samples were allowed to clot and centrifuged according to groups; and serum was separated for the biochemical analyses. The treated groups and control group were dissected and body organs (liver, kidneys, pancreases, spleen and testes) were excised and cleaned immediately from blood by rinsing with physiological saline and then fixed in 10% buffered formalin for histopathological examination.

2.4. Biochemical analyses {#sec0030}
-------------------------

Different biochemical tests were carried out using diagnostic kits to evaluate the toxicity of different doses of *Moringa* seeds and their effects on body function. Fasting blood glucose, expressed in mmol/L, was determined by (GOD/POD method) [@bib0115]. Serum insulin, expressed in ng/mL, was estimated by a radioimmunoassay [@bib0120]. Serum total cholesterol and triglycerides were measured colorimetric [@bib0125]. Liver enzymes, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) [@bib0130]; serum total protein concentration [@bib0135]. Serum Albumin was determined according to the method of Doumas, Watson [@bib0140]. Blood urea nitrogen, expressed in mg/dL, was assessed based on the cleavage of urea with urease according to the method of Karr [@bib0145]. Serum creatinine level (mg/dl) was determined colorimetric following the method of Heinegård and Tiderström [@bib0150]. Uric acid levels, expressed in mg/dL, was measured following the method of Kageyama [@bib0155]; Follicle-stimulating hormone (FSH), Luteinizing Hormone (LH) and testosterone were also measured according to manufacturer's structure of Midgley [@bib0160]; Niswender, Midgley Jr [@bib0165] and Vermeulen, Verdonck [@bib0170], respectively.

2.5. Histopathological examination {#sec0035}
----------------------------------

Selected organs including pancreas, spleen, liver, kidneys, and testes of treated and control rats were fixed in 10% buffered formalin in labeled bottles [@bib0175], and processed for histological examination [@bib0180]. Tissues embedded in paraffin wax were sectioned 5 mm thick, stained with Haematoxylin and Eosin, mounted on glass slides and examined under a standard light microscope. Light microscopic examinations of multiple tissue sections, from each organ in all groups, were performed and images representative of the typical histological profile were examined.

2.6. Statistical analysis {#sec0040}
-------------------------

All data obtained, expressed in mean ± standard error (SE), were statistically analyzed by the one-way ANOVA. The significance of the difference versus the control group was determined by Student's *t*-test. For ranking the data, Duncan Multiple Range test was applied. Values were considered statistically significant at *p *≤ 0.05. The Statistical Package for Social Sciences (SPSS) program, version 20, was used to run the statistical analyses.

3. Result {#sec0045}
=========

In the oral toxicity assay, all treated groups of rats at different doses of *M. peregrina* seeds (500, 1000 and 2000 mg/kg body weight) did not show any alternation in behavioral signals with no mortality during the time period of the study.

3.1. Biochemical studies {#sec0050}
------------------------

The biochemical results obtained from the oral *Moringa*-treated rats showed the safety use of *M. peregrina* seeds at all tested doses (500, 1000 and 2000 mg/kg body weight) when compared to control. For fasting serum glucose level, all *Moringa*-treated groups able to lower the level of blood sugar of the experimental rats ([Fig. 1](#fig0005){ref-type="fig"}) and at dose 500 (mg/kg BW) highly significant decreases (33.121 ± 2.31 vs. 53.25 ± 3.92, *p ≤ 0.01*) was recorded when compared to control group. On the contrary, *M. peregrina* seeds did not significantly (*p ≤* *0.05*) alter the level of insulin among treated and untreated groups ([Fig. 2](#fig0010){ref-type="fig"}). Although there was no significant differences among treated and control groups, *Moringa* dose at 2000 mg/kg BW showed the lowest level of insulin compared to control group (0.045 vs. 0.049 ng/mL; respectively).Fig. 1Effect of *Moringa peregrina* seeds on fasting blood sugar levels (FBS, mmol/L) compared to control group. Doses of Moringa seeds (mg/kg body weight) used: 1, control, no treatment; 2, 500; 3, 1000 and 4, 2000.\*\**p* ≤ 0.01, vs. control group; n = 6 in each group; values are in mean ± SE.Fig. 1Fig. 2Effect of *Moringa peregrina* seeds on serum insulin levels (ng/mL) compared to control group. Doses of *Moringa* seeds (mg/kg body weight) used: 1, control; 2, 500; 3, 1000 and 4, 2000. n = 6 in each group; values are in mean ± SE.Fig. 2

Cholesterol and triglyceride showed different concentration patterns in different *Moringa*-treated rats where cholesterol, at *Moringa* dose 1000 mg/kg body weight, recorded the highest ability for lowering the cholesterol (131.72 ± 8.64) at significant level of *p* ≤ 0.01 ([Table 1](#tbl0005){ref-type="table"}). However, Triglyceride level reported high significant (*p *≤ 0.01) decline at all *Moringa* doses and reached its lowest value at dose 500 mg/kg BW (78.68 ± 21.36) followed by *Moringa* doses at 1000 and 2000 (mg/kg BW) in sequence ([Table 1](#tbl0005){ref-type="table"}).Table 1Biochemical measured parameters of Cholesterol, Triglyceride, liver enzymes (ALT and AST), Albumin and Total protein concentrations in blood serum of Albino rats orally administered by *Moringa* seeds at different doses, 500, 1000 and 2000 mg/kg body weight, compared to untreated (Control) group. Measured parameters are in mean (±SE).Table 1TreatmentMeasured parameters (Mean ± SE)[\*](#tblfn0005){ref-type="table-fn"}(mg/kg BW)Cholesterol (mg/dL)Triglyceride (mg/dL)ALT (IU/L)AST (IU/L)AST/ALTAlbumin (g/dL)Total Protein (g/dL)Control191.26 ± 8.81 ^c^143.97 ± 12.93^b^70.21 ± 6.36 ^b^174.18 ± 8.82 ^b^2.5/13.29 ± 0.333.89 ± 0.48500164.39 ± 3.11 ^b^78.68 ± 8.72 ^a^24.19 ± 4.16 ^a^152.37 ± 7.06^ab^6.0/13.83 ± 0.144.13 ± 0.361000131.72 ± 8.64 ^a^91.76 ± 8.65 ^a^39.33 ± 2.65 ^a^145.80 ± 3.11 ^a^3.7/14.11 ± 0.414.84 ± 0.642000153.45 ± 2.78 ^ab^93.70 ± 8.07 ^a^33.96 ±2.92 ^a^145.43 ± 6.23 ^a^4.3/13.57 ± 0.173.98 ± 0.24[^1]

The result of liver enzymes revealed the significant (*p* ≤ 0.001) effect of *Moringa* seeds on lowering the level of Alanine aminotransferase enzyme (ALT) and Aspartate aminotransferase (AST) compared to the control group ([Table 1](#tbl0005){ref-type="table"}). The reduction of ALT was significantly pronounced at dose 500 mg/kg BW and recorded 24.19 ± 4.16 (IU/L). The higher doses of *M*. seeds were also significantly decreased the ALT level in serum by 0.7 and 1.72 time less than control group for 1000 and 2000 mg/kg BW, respectively ([Table 1](#tbl0005){ref-type="table"}). *Moringa* seed-supplement efficiently reduced the AST level to 145.43 ± 6.23 U/L (*p* ≤ 0.001) compared to untreated control (174.18 ± 8.82 U/L). AST/ALT ratio showed normal level and not exceeded the upper normal limits ([Table 1](#tbl0005){ref-type="table"}).

Urea, uric acid and creatinine levels in serum, expressed as mg/dL, were clearly demonstrated the positive influence of *Moringa* seeds on treated rats where there were decreases in their levels compared to control group. However, no significant differences were recorded among groups for each test (*p *≤ 0.193, 0.153 and 0.154, respectively, [Table 2](#tbl0010){ref-type="table"}). Tested rats administered different doses of *Moringa* seeds also showed a nonsignificant increase in serum total protein level when compared to that of the control group (4.13 ± 0.36, 4.84 ± 0.64, 3.98 ± 0.24 and 3.98 ± 0.24 for 500, 1000 and 2000 mg/kg vs. 3.89 ± 0.48, respectively). Similarly, the effect of *M*. seeds on serum albumin revealed a positive influence on increasing the level of serum albumin to 4.11 ± 0.41 vs. 3.29 ± 0.33 for rate administrated *Moringa* seeds at dose 1000 mg/kg BW and untreated group respectively. However, no significant difference was detected among treated and untreated-control groups ([Table 2](#tbl0010){ref-type="table"}).Table 2Biochemical measured parameters of Urea, Uric acid and creatinineconcentrations in blood serum of Albino rats orally administered by *Moringa* seeds at different doses, 500, 1000 and 2000 mg/kg body weight, comparedto untreated control group. Measured parameters are in means (±SE).Table 2TreatmentMeasured parameters (Mean ± SE)Urea (mg/dL)Uric acid (mg/dL)creatinine (μmol/L)Control90.54 ± 15.102.53 ± 0.620.88 ± 0.1950070.08 ± 7.831.55 ± 0.450.76 ± 0.18100084.79 ± 4.361.64 ± 0.840.46 ± 0.12200089.83 ± 10.831.64 ± 0.410.43 ± 0.13

The effect of *Moringa* seeds on male sex hormones is shown in [Fig. 3](#fig0015){ref-type="fig"}(a--c). The administration of *M*. seeds enhanced the levels of LH, FSH and Testosterone hormones compared to control group. The increments in hormonal levels were not significantly different at *p *≤ 0.05. In addition, it was noticeable that the effect of *M*. seeds was higher in all hormones detected at does 1000 mg/kg BW, where it recorded 0.042, 0.12 and 0.33 for LH, FSH and Testosterone, respectively.Fig. 3Effect of *Moringa peregrina* seeds on serum sex hormones (ng/mL) of LH (a), FSH (b) and Testosterone (c). Doses of *Moringa* seeds (mg/kg body weight) used: 1, control; 2, 500; 3, 1000 and 4, 2000. n = 6 in each group; values are in mean ± SE.Fig. 3

3.2. Histopathological findings {#sec0055}
-------------------------------

The histology of the pancreas of untreated and treated groups with *Moringa* seeds at all doses used ([Fig. 4](#fig0020){ref-type="fig"}A--D) revealed the normal architecture of the pancreas cells which include prominent Langerhans islets, acini cells and ducts. The pancreas showed profuse islet of Langerhans interspersed within the pancreatic exocrine acini. The islets appeared lightly stained than the surrounding acini cells, with intact normal interlobular connective tissue and interlobular duct. Each endocrine islet consisted of lightly stained polygonal cells arranged in cords separated by a network of blood capillaries. However, the exocrine acini cells were characterized by their basal basophile and apical acidophilic cells. No area of cell necrosis was observed.Fig. 4Effect of *Moringa peregrina* seeds on pancreas tissue architecture compared to control group. A-D, TS in pancreas tissue showing normal lobular architecture, Islets of Langerhans (ISL, yellow arrows) surrounded by the pancreatic acini and duct. The pancreatic acini clearly showed normal basal basophilic and apical acidophilic cells with no cell boundary. 100 X, for A--C; 200 X for D. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 4

The effect of *Moringa* seeds, at different doses, on spleen compared to untreated control group showed normal spleen tissues ([Fig. 5](#fig0025){ref-type="fig"}A--D). The tissues are clearly differentiated into white pulps (WP) and the red pulps (RP). The architecture of the white pulps displayed normal rounded scattered follicles with an arteriole on one side called central arterioles on which cells are arranged around the arteriole and classified into four zones: Thymus dependent zone which contains lymphocyte cells around the arteriole; Germinal center is second zone and appeared as lightly-stained areas in the center of secondary lymphoid follicles; Follicular zone is third zone that consists of B-Lymphocytes and Marginal zones, which exist at the periphery, is the fourth zone which was easily distinguished ([Fig. 5](#fig0025){ref-type="fig"}).Fig. 5Effect of *Moringa peregrina* seeds on spleen histology compared to control group. A-D, TS in spleen tissue showing normal tissue architecture, white pulp (WP, double yellow arrows); red pulp (RP, red arrow); zones of white pulp are normally represented, germinal central (GC), arteriole (A, arrow head), follicle zone (FZ) and marginal zone (MZ). No abnormalities in these tissues were observed. A, control group; B, group administered 500 mg/kg BW; C, group administered 1000 mg/kg BW and D, group administered 200 mg/kg BW. 100X. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 5

The results of histopathological examination of the liver of control and *Moringa*-treated rats showed no hepatic inflammation, degeneration, vacuolization and necrosis ([Fig. 6](#fig0030){ref-type="fig"}A--D). The microscopically examined liver tissue also revealed the presence of normal hepatic parenchyma with the plates of hepatocytes being separated by sinusoids. The central vein was observable and had normal appearance ([Fig. 6](#fig0030){ref-type="fig"}). The portal triad, artery, vein and bile duct branches were also seen and showed normal tissue morphology. In general, for all treatment does of *M*. seeds compared to control group showed that the liver tissues, as a whole, are healthy and have normal microscopically structural appearance ([Fig. 6](#fig0030){ref-type="fig"}).Fig. 6Effect of *Moringa peregrina* seeds on liver tissue architecture compared to control group. A--D, TS in classic hepatic lobule, showing normal architecture of central vein (arrow) with hepatocytes arranged in plates or cords radiating from central vein and separated by blood sinusoids, each cord formed of two or more rows of hepatocytes inclosing between them bile canaliuli. Portal vein, hepatic artery and bile duct (liver triad), represented in yellow circle, are observed between hepatic lobules. A, control group; B, group administered 500 mg/kg BW; C, group administered 1000 mg/kg BW and D, group administered 200 mg/kg BW. 100X. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 6

The kidney tissues of all groups, designed in this study, showed normal healthy feature where the renal histological structures of renal parenchyma are being illustrated histologically as represented in the photomicrographs ([Fig. 7](#fig0035){ref-type="fig"}A--D). The cortical structures especially the glomerulus as a whole reflected quite well defined constituting elements. The neighboring renal tubules, both proximal and distal convoluted, were clearly observable and have normal architecture ([Fig. 7](#fig0035){ref-type="fig"}). Similarly, the histological architectures of testicular tissues of the control and treated animals showed normal structure ([Fig. 8](#fig0040){ref-type="fig"}A--D). The seminiferous tubules were well defined and the interstitial tissues were also defined. Similarly, the seminiferous tubule epithelium was well distinct and had a normal histoarchitecture. Differential stages for spermatogenesis development were clearly observed ([Fig. 8](#fig0040){ref-type="fig"}). In meantime, spermatozoa in the lumen of seminiferous tubules showed increment in number compared to control group.Fig. 7Effect of *Moringa peregrina* seeds on kidney histological architecture compared to control group. A-D, T.S. of kidney, showing normal architecture of glomerulus (arrow); proximal convoluted tubule(PCT) and distal convoluted tubule (DCT, yellow circle). A, control group; B, group administered 500 mg/kg BW; C, group administered 1000 mg/kg BW and D, group administered 200 mg/kg BW. 100X. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 7Fig. 8Effect of *Moringa peregrina* seeds, at different doses, on tests histology compared to control group, A-D, T.S. of tests, showing normal seminiferous tubules (ST) in between there are leydg cells (L). Sertoli cells and spermatogenic cells, laying inside the seminiferous tubules, are also observed. A, control group; B, group administered 500 mg/kg BW; C, group administered 1000 mg/kg BW and D, group administered 200 mg/kg BW. 100X.Fig. 8

4. Discussion {#sec0060}
=============

The uses of herbal plants as a source of folk medicines in primary health care have become popular globally as a safer drug because of their natural source. *Moringa* species have been widely uses for their nutritional and medical values in different countries. In mean time, Egyptian *Moringa peregrina*, naturally occurred in Sinai Peninsula, is in use by local Bedouin, and nowadays it is used on a large scale but there is a lack of proven scientific studies on their toxicity and adverse effect on local and large scale. Therefore, the present study aimed to evaluate the toxicity of *Moringa peregrina* seeds in low and high doses that could be used for further pharmaceutical studies. Based on the results obtained there was no negative effects of *Moringa* seeds, daily administrated orally, for all treated groups of rats at different doses (500, 1000 and 2000 mg/kg body weight) were observable. After an observation period of 2 weeks following seed administration, no mortality or any alternations in appearance or behavioral signals occurred during the time period of the study. These results proved the safety use of *Moringa* seeds orally. Our results are in agreement with study done by kahilo, Kamal [@bib0185] who found that no changes in animal behavior in the male rats received orally *M. peregrina*-oil at dose 3000 mg/kg BW.

Based on the biochemical assays, our results confirmed that administration of *M*. seeds have safety beneficial uses where serum blood sugar levels exhibited significant lower level (*p *≤ 0.01), at all doses used, compared to control group. These result was aligned with nonsignificant slight increase in serum insulin, for treated groups, which may considered as sensitive monitoring for blood sugar compared to control group. This suggestion corroborates the histological report of the pancreas which showed normal architecture and no damage to islets of Langerhans. The results further showed significant decrease in cholesterol and triglyceride which endorse the beneficial effect of *M*. seeds even at high doses. When *M*. seeds at different doses, in particular 1000 mg/kg BW, was administered to normal rats, anti-hyperglycemic and anti-hyperlipidaemic response were seen compared to control levels. These effects of various doses of *M*. seeds are credited to their ability to restore the function of pancreatic tissues by causing an increase in the insulin output [@bib0190] and/or by inhibiting the intestinal absorption of glucose or by the facilitation of metabolites in insulin-dependent processes [@bib0195], [@bib0200].

In reference to data obtained, *Moringa peregrina* seeds did not produce any deleterious effects on the spleen tissue; there however may lead to an improvement in the structural architecture that may be coded or transformed into improvement on physiological functioning of the tissue. This suggestion could be confirmed due the important role of spleen tissue in body immunity [@bib0205]. Similarly, liver enzymes and its structure proved the positive effect of *M.* seeds at all doses where there were significant decrease in ALT and AST when compared to control group. Low dose of *M.* seeds (500 mg/kg BW) was more pronounced for lowering the ALT, vice versa for AST where higher doses (1000 and 2000 mg/kg BW) recorded the lowest level when compared to control group. These results reflect the normal liver architecture.

For kidney function,*Moringa* seed-supplements maintain healthy condition for kidney tissues where there were nonsignificant decrease in the urea, uric acid, creatinine and nonsignificant increase total protein and Albumin levels in serum of *M.* groups compared to control group. In addition, rat treated with all the doses of *M. peregrina* did not show any morphological changes in the kidney cells. Our data recorded is in agreement to kahilo, Kamal [@bib0185] who found that normal liver and kidney histological structure to rats received *Moringa peregrina* seeds oil (3000 mg/kg BW).

The effect of *M. seeds* in enhancing male fertility is clearly manifested in all the treated *M.* groups compared with the control. However, rats administered with medium doses 1000 mg/kg BW of the plant seeds showed the highest nonsignificant increase in FSH, LH and testosterone levels. The normal of histoarchitectural of testes tissues was the clear indication of confirming the spermatogenic efficacy of *M. peregrina* seeds in male albino rats. The process of spermatogenesis and accessory reproductive organ function are hormonal dependent. FSH in male rats are crucial for the establishment of Sertoli cell population, which is directly related to sperm production [@bib0210], [@bib0215]. However, LH stimulates spermatogenesis indirectly via stimulation of Leydig cells to secrete testosterone, which acts also on Sertoli cells [@bib0220]. *M. peregrina* seeds were able to induce Spermatozoa density in the lumen of seminiferous tubules of rats testes. The observed increment may reflect the possible antioxidant effect of *M*. seeds [@bib0065], [@bib0185]. Moreover, the chemical constituent of *M.* seeds contain polyunsaturated fatty acids [@bib0225], [@bib0230] that may also play an important role in increasing the fertility and reproduction [@bib0235], [@bib0240].

The above mentioned results of the current study on the biochemical analyses (AST, urea, creatinine, urea, uric acid, albumin, total protein, FSH, LH and testosterone) and the histopathological studies of (pancreas, spleen, liver, kidney and testes) may therefore suggest that *M. peregrina* seeds are safe in use for food grade substance in the rats with no deleterious effect. Meanwhile, it is suggested to be used as alternative natural drug (herbal medicine) for lowering blood sugar (anti-hyperglycemic) and triglyceride and cholesterol (anti-hyperlipidaemic).

5. Conclusion {#sec0065}
=============

In summary, based on the biochemical measured parameters and histological observations evaluated on this study, we conclude that Egyptian *M. peregrina* seeds have a broad safety potential for therapeutic use, since no mortality or any sign of toxicity observed. Therefore, it can be used on large scale without fear of its side effects. Also, from the current investigation we suggested that taken Egyptian *M. peregrina* seeds in meals will help to control hyperglycaemia and hyperlipidaemia for people suffering of high risk to diabetes and high blood pressure. The above mentioned results represented in this study will benefit our future studies of *M. peregrina* seeds, as they will be used as an alternative dose in treatment and control liver enzymes and kidney damage. Dose declaration above the doses used, in our study, should have further studies and be incorporated into regulatory guidance to have optimal benefits as natural drug.
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[^1]: Means with the same letter, per each column, are not significantly different according to Duncan's multiple test, *p* ≤ 0.05, n = 6.
